AH053 - Selling Pharmacy Benefits: Relationships, Rebates, GLP-1s, and More, with Bridget Mulvenna

On Episode 53 of the Astonishing Healthcare podcast, Bridget Mulvenne, VP of Business Development, joins Justin Venneri in the studio again to share highlights of her first full year of selling pharmacy benefit solutions ahead of her webinar on February 13: 5 Ways to Improve your PBM Procurement Process in 2025 (click here to learn more and register). They discuss the evolving healthcare landscape, regulatory pressures, expanding indications for GLP-1s, and the need for transparency in pharmacy benefits. Bridget shares stories from the field, explaining why focusing on drug manufacturer revenue and breaking the industry’s dependence on rebates are so important and how modern technology helps provide real-time data access and actionable insights to plan sponsors. Previous AH episodes featuring Bridget:AH002 - A Former Pharmacy Program Director's View on Controlling Pharmacy CostsAH021 - Managing Pharmacy Costs in a GLP-1 World, with Bridget MulvennaBridget also shares insights on the evolving landscape of GLP-1 medications and their growing number of FDA-approved indications beyond diabetes and highlights the challenges plan sponsors face with coverage decisions, balancing short-term costs with potential long-term savings. Discussing Capital Rx’s Never Move Again™ offering, Bridget emphasizes its flexibility and appeal to sophisticated plan sponsors.Related Content:Pharmacy Benefits 101: Pharmaceutical RebatesOur Single-Ledger Model™ - Pharma Revenue ExplainedAH030 - Plan Sponsors Need a Source of Truth; Get Your Data Now & Find It, with Jeff HoganPlease visit Capital Rx Insights for more information, including this episode's transcript!